A pilot study of the effects of losartan vs. placebo on pneumoproteins in HIV: A secondary analysis of a randomized, double blind, study.
Sign Up to like & getrecommendations! Published in 2021 at "AIDS research and human retroviruses"
DOI: 10.1089/aid.2020.0285
Abstract: Human immunodeficiency virus (HIV) is an independent risk factor for lung disease, including chronic obstructive pulmonary disease (COPD) and emphysema. Angiotensin receptor blockers may be beneficial in COPD and emphysema through pathways that have been… read more here.
Keywords: effects losartan; losartan placebo; placebo; spd ... See more keywords